Providence Medical Technology
Privately held US medical device company in Pleasanton, California, that develops tissue-sparing posterior cervical and lumbar spinal fusion implants and instruments, including the CORUS PCSS 3D-T implant made of 3D-printed porous titanium.
- CEO / Founder
- Lane Major
- Stage
- Active
- Total Funding
- $105M
- Latest Round
- Series E
- Key Investors
- MVM Life Science Partners; Stanmore Medical Investments; Capital Growth Medvest; Columbia Threadneedle Investments; Aphelion Capital; SVB Financial Group; Revelation Partners
Technology & Products
Key Products
CORUS Spinal System; CORUS PCSS posterior cervical stabilization system; CORUS PCSS 3D-T (3D-printed porous titanium, FDA 510(k) cleared in 2026); CAVUX ffs and CAVUX cervical cages; ALLY screw systems; ENTRUS allograft bone; DiViNE portal system; CORUS-LX LevelOne lumbar system; CORUS Navigation Access System. The earlier product line was DTRAX.
Technological Advantage
Proprietary posterior cervical facet fusion approach; navigation-compatible lumbar facet implants; an intellectual property portfolio; and Level 1 clinical evidence. Note that the randomized trial evaluated the prior-generation machined CORUS PCSS, not the porous 3D-T version.
Differentiation
Value Proposition
The company promotes Total Segmental Fusion (TSF) and Circumferential Cervical Fusion (CCF), which add posterior facet stabilization to anterior fusion. The stated goal is higher fusion rates in high-risk patients with little added morbidity and no change in hospital length of stay. A multicenter randomized controlled trial (Spine, 2025) is cited as supporting evidence.
How They Differentiate
The company focuses specifically on posterior facet-based Total Segmental Fusion using a tissue-sparing approach, rather than broad spine portfolios. It pairs this with Level 1 randomized controlled trial data and now offers a 3D-printed porous titanium implant option within the same surgical workflow.
Market & Competition
Target Customers
Spine surgeons, including neurosurgeons and orthopedic spine surgeons, and the hospitals and ambulatory surgery centers that perform cervical and lumbar fusion on patients with degenerative spine conditions.
Industry Verticals
Medical devices; spine surgery (cervical and lumbar fusion)
Competitors
SI-BONE; ATEC Spine (Alphatec); Paradigm Spine
Growth & Milestones
Growth Metrics
The company reports growing adoption of CORUS across cervical and lumbar markets, accelerated by its navigated solutions launch (August 2026). Funding totals vary by database, from $58M (Tracxn) to $105M (PitchBook).
Major Milestones
2008: founded (co-founders Bruce McCormack MD and Jeff Smith). 2017: FDA 510(k) clearance for ALLY screw system; $10.5M financing led by MVM. 2018: $25M equity financing. 2025: 24-month multicenter RCT published in Spine. Aug 2026: Lane Major appointed President & CEO. Oct 2026: FDA 510(k) clearance for CORUS PCSS 3D-T 3D-printed porous titanium implant, debuting at NASS 2026 in San Antonio.